Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Highly active antiretroviral therapy

Peter Mugyenyi

    BMJ (Clinical Research Ed.)
    |November 13, 2004
    PubMed
    Summary

    No abstract available in PubMed .

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Third-line antiretroviral therapy, including raltegravir (RAL), darunavir (DRV/r) and/or etravirine (ETR), is well tolerated and achieves durable virologic suppression over 144 weeks in resource-limited settings: ACTG A5288 strategy trial.

    Journal of the International AIDS Society·2022
    Same author

    Translocated microbiome composition determines immunological outcome in treated HIV infection.

    Cell·2021
    Same author

    Effectiveness of a mobile antiretroviral pharmacy and HIV care intervention on the continuum of HIV care in rural Uganda.

    AIDS care·2020
    Same author

    Diverse Human Immunodeficiency Virus-1 Drug Resistance Profiles at Screening for ACTG A5288: A Study of People Experiencing Virologic Failure on Second-line Antiretroviral Therapy in Resource-limited Settings.

    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2019
    Same author

    Two-way mobile phone intervention compared with standard-of-care adherence support after second-line antiretroviral therapy failure: a multinational, randomised controlled trial.

    The Lancet. Digital health·2019
    Same author

    Third-line antiretroviral therapy in low-income and middle-income countries (ACTG A5288): a prospective strategy study.

    The lancet. HIV·2019
    Same journal

    Peptides: FDA appointed advisory committee criticised for conflicts of interest.

    BMJ (Clinical research ed.)·2026
    Same journal

    Hantavirus outbreak linked to cruise ship is over, say officials.

    BMJ (Clinical research ed.)·2026
    Same journal

    BMA recommends that 16 and 17 year olds get access to cross sex hormones.

    BMJ (Clinical research ed.)·2026
    Same journal

    Andy Burnham could apply lessons from Manchester to create a healthier Britain with a stronger economy.

    BMJ (Clinical research ed.)·2026
    Same journal

    Uganda confirms Marburg case as Ebola outbreak continues.

    BMJ (Clinical research ed.)·2026
    Same journal

    Australia increases penalties for social media companies to enforce under 16s ban.

    BMJ (Clinical research ed.)·2026
    See all related articles